Provided by Tiger Trade Technology Pte. Ltd.

Biogen

228.60
-0.8150-0.36%
Volume:322.64K
Turnover:73.88M
Market Cap:33.75B
PE:40.60
High:231.04
Open:230.34
Low:227.50
Close:229.41
52wk High:238.24
52wk Low:138.00
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.64
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.79
PE(LYR):26.01

Loading ...

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Sector Update: Healthcare Stocks Rise Late Afternoon

MT Newswires Live
·
Yesterday

Biogen Shares Rise After JPMorgan Upgrade

MT Newswires Live
·
Yesterday

Biogen on Track for Highest Close Since July 2024

Dow Jones
·
Yesterday

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Yesterday

US Stocks on the MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences

Reuters
·
Oct 12

Biogen price target raised to $220 from $208 at BMO Capital

TIPRANKS
·
Oct 12

Biogen Gets JPMorgan Upgrade Ahead of Key Data Readouts

Dow Jones
·
Oct 12

Biogen Price Target Raised to $300.00/Share from $210.00 by JP Morgan

Dow Jones
·
Oct 12

Biogen : Bmo Raises Target Price to $220 from $208

THOMSON REUTERS
·
Oct 12

U.s. Stocks on the Move-GoDaddy, Biogen, Iren

Reuters
·
Oct 12

BMO Capital Adjusts Price Target on Biogen to $220 From $208

MT Newswires Live
·
Oct 12

J.P. Morgan Upgrades Biogen to 'overweight', Shares Rise

Reuters
·
Oct 12

Biogen Shares Rise 2.1% Premarket After JP Morgan Raises to Overweight from Neutral

THOMSON REUTERS
·
Oct 12

Biogen : JP Morgan Raises to Overweight from Neutral; Raises Target Price to $300 from $210

THOMSON REUTERS
·
Oct 12

U.S. Stocks on the MOVE -VF Corp, Biogen, AbbVie

Reuters
·
Oct 10

UBS Lifts Biogen PT on Late-Stage Pipeline Catalysts; Shares Rise

Reuters
·
Oct 10

Biogen Price Target Raised to $270.00/Share from $240.00 by UBS

Dow Jones
·
Oct 09

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Oct 09

UBS Adjusts Price Target on Biogen to $270 From $240, Maintains Buy Rating

MT Newswires Live
·
Oct 09